Promisingly, the Ub system has become a prominent target for drug discovery to treat cancers, with DUB inhibitors now progressing into clinical trials (Harrigan et al., 2018, Huang and Dixit, 2016, Pinto-Fernandez and Kessler, 2016). This evidence concerns the gene ZUP1 and cancer.